Form N-PX JOHNSON & JOHNSON For: Jun 30
ATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Erste Group Downgrades Johnson & Johnson (JNJ) to Hold
- Johnson & Johnson announces new data showing TREMFYA® (guselkumab) is the only IL-23 to deliver durable fistula remission through 48 weeks in Crohn's disease with perianal fistula
- C5 Resins Market Size to Grow at 3.93% CAGR Through 2031 as Packaging and Adhesive Demand Expands | Mordor Intelligence Report Says
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share